FDA requires trials of COVID shots for healthy kids, adults GERRY SMITH Bloomberg News May 20, 2025 U.S. regulators will no longer approve COVID booster shots for healthy adults and children without new studies, adding a costly requirement fo…
FDA sets COVID booster guidelines requiring trials for approval By Michael Erman Reuters May 20, 2025 NEW YORK â€� U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy U.S. ci…
FDA approves Novavax COVID vaccine with new conditions By Reuters May 17, 2025 U.S. Food and Drug Administration ohas approved Novavax's COVID-19 vaccine, but placed additional conditions on individuals who would be able …
FDA aims to remove fluoride supplements for children By Reuters May 13, 2025 U.S. Food and Drug Administration on Tuesday said it is starting a process to remove from the market fluoride supplements for children.
FDA names agency critic Prasad as top vaccine official By Dan Levine and Julie Steenhuysen Reuters May 6, 2025 U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has criticized FDA leadership and COVID-19 mandates, as director o…
Nonpartisan poll finds ‘remarkably lowâ€� trust in federal health agencies By Jennifer Shutt News From The States May 6, 2025 Less than half of Americans have confidence in federal public health agenciesâ€� ability to regulate prescriptions, approve vaccines and respond…
US FDA chief says firings won't hinder agency's target dates for drug reviews Apr 29, 2025 (Reuters) -The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the agency …
FDA delays decision on Stealth BioTherapeutics' rare genetic disorder drug Apr 29, 2025 (Reuters) -The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment for a r…
FDA approves first cell-based gene therapy for rare genetic skin disorder By Sneha SK and Kamal Choudhury Reuters Apr 29, 2025 U.S. Food and Drug Administration on Tuesday approved Abeona Therapeutics' gene therapy for a rare skin disorder.
Medicine companies brace for tariffs, while weighing additional concern By Reuters Apr 24, 2025 Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they grapple with the thr…
